NCT01391741

Brief Summary

People with disease (PD) tend to walk with short steps, decreased velocity, and increased stride time variability. Short steps and increased variability are related to greater fall risk. In addition, concurrent performance of a cognitive task (dual-task (DT)) has marked effects on gait in people with PD which is considered to reflect an impaired automaticity of gait. Objective: To investigate short and long term effects of high-volume walking with visual spatial cues (VSC) on gait variables, automaticity, and functional mobility, in people with Parkinson´s Disease (PD), compared with walking without VSC.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Apr 2008

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2008

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2008

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

July 7, 2011

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 12, 2011

Completed
Last Updated

July 12, 2011

Status Verified

March 1, 2010

Enrollment Period

5 months

First QC Date

July 7, 2011

Last Update Submit

July 11, 2011

Conditions

Keywords

Parkinson´s DiseaseWalkingExerciseAutomaticityDual TaskVisual CuesCueingNeuroplasticityGait analysis

Outcome Measures

Primary Outcomes (3)

  • Change in Step Length

    Before, after and 3 months after a 4 week training period

  • Change in Gait Velocity

    Before, after and 3 months after a 4 week training period

  • Change in Stride Time Variability

    Before, after and 3 months after a 4 week training period

Secondary Outcomes (1)

  • Change in Timed Up & Go (seconds)

    Before, after and 3 months after a 4 week training period

Study Arms (2)

Walking with visual cues

EXPERIMENTAL

Walking with visual cues for 30 minutes, 4 times a week for 4 weeks

Other: Visual Cues

Walking without visual cues

ACTIVE COMPARATOR

Walking without visual cues, but verbal encouragement twice a week to take longer steps, for 30 minutes, 4 times a week for 4 weeks.

Other: Walking without visual cues

Interventions

Walking with visual cues for 30 minutes, 4 times a week for 4 weeks

Walking with visual cues

Walking without visual cues, but verbal encouragement twice a week to take longer steps, for 30 minutes, 4

Walking without visual cues

Eligibility Criteria

AgeUp to 79 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • a confirmed diagnosis of PD according to the UK Parkinson´s Disease Society Brain Bank Clinical Diagnostic Criteria (18)
  • \<80 years of age
  • community residing
  • Hoehn and Yahr (HY) stage 2-3
  • Mini Mental State Examination (MMSE) score of \>23
  • ability to walk without walking aids for a total of 20 minutes over a 30-minute period

You may not qualify if:

  • major modifications of Parkinson´s medication (Madopar \>200 mg/d or \>20% increase in Dopamine agonists) 3 weeks prior to baseline assessment
  • comorbidities or disabilities, which might influence walking
  • a history of brain surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Reykjalundur Rehabilitation Center

Mosfellsbaer, 270, Iceland

Location

MeSH Terms

Conditions

Parkinson DiseaseMotor Activity

Interventions

Walking

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesBehavior

Intervention Hierarchy (Ancestors)

LocomotionMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExerciseMotor Activity

Study Officials

  • Andri T Sigurgeirsson, M.Sc.

    University of Iceland / Reykjalundur Rehabilitation Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 7, 2011

First Posted

July 12, 2011

Study Start

April 1, 2008

Primary Completion

September 1, 2008

Study Completion

September 1, 2008

Last Updated

July 12, 2011

Record last verified: 2010-03

Locations